500 patients67,039 observations150 daysLIVE
← Patients

Patient P-03445

Synthetic patientONX-7 · Day 135 · 55–64 · F · baseline S10Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
16%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 started — Baseline state S10

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Toxicity+17
  • GI instability-8
  • Inflammatory activity+4
  • Nutritional resilience-3

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Energy level
    Daily log
    5.1/10
    worsening · -0.5 vs previous 14 d
    Stress level
    Daily log
    4.5/10
    worsening · +0.8 vs previous 14 d
    Pessimism score
    Daily log
    3.7/10
    worsening · +0.4 vs previous 14 d
    Sleep quality
    Wearable
    54.8/100
    worsening · -7.0 vs previous 14 d
    Libido
    Daily log
    3.8/10
    worsening · -0.6 vs previous 14 d
    HRV
    Wearable
    59.1 ms
    worsening · -3.6 vs previous 14 d
    Toxicity
    Blood
    26.9/100
    worsening · +1.1 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 74 from the failing basin, 17 from restoration.

    Would help
    • No untried action with strong evidence. Compose one from primitives.
    • More protein
      GI -5.8 next day on high-intake days · n 24
    Would not help
    • AD-05 Adherence Support
      only 36% improved among 14 similar
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -5.8supporter · 95%
    • Dietary fat load
      +1.7no signal · 33%
    • Histamine load
      +1no signal · 23%
    • Lactose
      -1no signal · 20%
    • Caffeine
      +0.5no signal · 15%
    • Alcohol
      +0.2no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
      DNA
      Fictional pharmacogenomic panel
      • CYP2D6 Intermediate metabolizer
        Expected exposure
      Microbiome
      Shannon diversity 3 · butyrate capacity 76/100
      • Akkermansia muciniphilaNormal
      • Faecalibacterium prausnitziiNormal
      • Bacteroides fragilisNormal
      • Bifidobacterium longumLow
      • EnterobacteriaceaeNormal
      Wearable, last 14 days
      daily evolution fed into the runtime
      HRV
      59 ms
      Sleep
      6.2 h
      Steps
      6,791
      Resting HR
      68 bpm
      Daily log: GI score 18, nutritional resilience 67, adherence 91.

      What this patient sees in NostraAI

      The content that steers the trajectory: what to eat, what to do, what to take.

      Open companion preview
      What to eat
      • Keep meals regular; three to four moderate portions spaced through the day
      • Include a cooked vegetable portion with each main meal
      • Keep fibre steady; no new sources this week
      • Avoid known triggers for now: fried or oily food, dairy, alcohol
      What to do
      • Log the daily check-in; one line is enough
      • Keep the current walking rhythm
      • Keep the sleep window steady
      • Keep hydration steady: small amounts through the day rather than large volumes at once
      What to take
      • Take the scheduled dose as agreed with your care team
      • No additional supplements this week
      • Fictional demo item: continue vitamin D as before

      284 biologically similar trajectories

      Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

      Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
      PatientSimilarityBaselineInterventionOutcomeResponse today
      P-0310553%S12AD-05no change60
      P-0348239%S05AD-05no change67
      P-0320436%S16AD-05improved48
      P-0335135%S07AD-05no change51
      P-0318734%S12AD-05no change80
      P-0311133%S07AD-05no change48
      P-0342431%S12AD-05improved41
      P-0312230%S13AD-05no change40
      P-0336930%S18AD-05no change37
      P-0338030%S16AD-05improved34
      P-0344130%S19AD-05improved37
      P-0303429%S14AD-05no change30